Institution
Saitama Cancer Center
Also known as: 埼玉県立がんセンター
- 35running trials
- 30closed trials
- 4,744publications (OpenAlex)
Running trials
Recruiting
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer
Recruiting
Recruiting
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer6 recruiting
- Colorectal cancer5 recruiting
- Head and neck cancer3 recruiting
- Lung cancer3 recruiting
- Ovarian cancer3 recruiting
- Bladder cancer2 recruiting
- Cervical cancer2 recruiting
- Endometrial cancer2 recruiting
- Melanoma2 recruiting
- Metastatic breast cancer2 recruiting
- Pancreatic cancer2 recruiting
- Childhood cancers1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Liver and biliary tract cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Completed
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Registry name variants (14)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Saitama Cancer Center
Saitama, 362-0806
22 trials
Saitama Cancer Center
Kitaadachi-gun, Saitama 362-0806
17 trials
Saitama Cancer Center
Shinden, Saitama 362-0806
7 trials
Saitama Cancer Center
Ina, Kitaadati-gun, Saitama 362-0806
4 trials
Saitama Cancer Center
Kitaadachigun, 362-0806
4 trials
Saitama Cancer Center
Ina-machi, Kitaadati-gun, Saitama
2 trials
Saitama Cancer Center
Kitaadachi, Saitama 362-0806
2 trials
Saitama Cancer Center
Bunkyo-ku, Tokyo 113-8603
1 trial
Saitama Cancer Center
Ina-machi, Saitama 362-0806
1 trial
NCT07410117REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Contact: Clinical Trials Administrator
Saitama Cancer Center
Inamachi, 362-0806
1 trial
Saitama Cancer Center
Kita-adachi-gun, Saitama 362-0806
1 trial
Saitama Cancer Center
Kitaadachi-gun Ina-machi, Saitama
1 trial
NCT06901531A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Contact: Astellas Pharma Global Development Inc.
Saitama Cancer Center
Komoro, Saitama 362-0806
1 trial
Saitama Cancer Center
Saitama, Kitaadachi-gun, 362-0806
1 trial
Contact: Boehringer Ingelheim
Conditions
Diseases this institution publishes on or runs trials for.
- Gastric and oesophageal cancer37 works · 17 trials
Institution data: ROR 03a4d7t12 (CC0-1.0)Updated 15 Nov 2026